| __timestamp | Eli Lilly and Company | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4733600000 | 79838000 |
| Thursday, January 1, 2015 | 4796400000 | 121816000 |
| Friday, January 1, 2016 | 5243900000 | 117633000 |
| Sunday, January 1, 2017 | 5281800000 | 117456000 |
| Monday, January 1, 2018 | 5051200000 | 171984000 |
| Tuesday, January 1, 2019 | 5595000000 | 257452000 |
| Wednesday, January 1, 2020 | 6085700000 | 477643000 |
| Friday, January 1, 2021 | 7025900000 | 540684000 |
| Saturday, January 1, 2022 | 7190800000 | 651496000 |
| Sunday, January 1, 2023 | 9313400000 | 666563000 |
| Monday, January 1, 2024 | 14271000000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Eli Lilly and Company and PTC Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Eli Lilly's R&D expenses surged by nearly 97%, peaking at over $9.3 billion in 2023. This reflects a robust strategy to maintain its leadership in the industry. In contrast, PTC Therapeutics, Inc. has shown a more modest increase of approximately 735% in the same period, reaching $666 million in 2023. While Eli Lilly's spending dwarfs that of PTC, the latter's growth rate is impressive, highlighting its aggressive push to expand its research capabilities. This spending showdown underscores the diverse strategies companies employ to drive innovation and secure their future in the pharmaceutical landscape.
R&D Spending Showdown: Eli Lilly and Company vs Dr. Reddy's Laboratories Limited
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Madrigal Pharmaceuticals, Inc.
Comparing Innovation Spending: Eli Lilly and Company and Opthea Limited
Comparing Innovation Spending: Eli Lilly and Company and Ionis Pharmaceuticals, Inc.
Cost Insights: Breaking Down Eli Lilly and Company and PTC Therapeutics, Inc.'s Expenses
Eli Lilly and Company or Alkermes plc: Who Invests More in Innovation?
Eli Lilly and Company vs Veracyte, Inc.: Strategic Focus on R&D Spending
Eli Lilly and Company or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
Eli Lilly and Company vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
GSK plc vs PTC Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Bio-Techne Corporation and PTC Therapeutics, Inc.
R&D Insights: How Sarepta Therapeutics, Inc. and PTC Therapeutics, Inc. Allocate Funds